Table: Fuji Pharma -2025/26 group results

Fuji Pharma

10/11/2026 07:30

Nov 10 (Reuters)-
Fuji Pharma
CONSOLIDATED FINANCIAL HIGHLIGHTS

 (in billions of yen unless specified)

             Year ended    Year ended     Year to         NEXT
           Sep 30, 2026  Sep 30, 2025  Sep 30, 2027      YEAR
              LATEST       YEAR-AGO      COMPANY       COMPANY
             RESULTS       RESULTS       FORECAST    H1 FORECAST
Sales         62.39         51.68         69.19         32.92
           (+20.7 pct)   (+12.0 pct)   (+10.9 pct)   (+10.8 pct)
Operating      6.36          4.99          7.42          2.97
           (+27.4 pct)   (+28.6 pct)   (+16.8 pct)   (-32.5 pct)
Recurring      6.18          4.46          6.91          2.72
           (+38.5 pct)    (+0.3 pct)   (+11.9 pct)   (-36.2 pct)
Net            2.83          3.00          4.88          1.94
            (-5.6 pct)   (-51.2 pct)   (+72.4 pct)   (+172.0 pct)
EPS         111.18 yen    122.94 yen    186.83 yen    74.27 yen
Ann Div     52.00 yen     45.50 yen     58.50 yen
-Q2 div     23.00 yen     20.00 yen     28.00 yen
-Q4 div     29.00 yen     25.50 yen     30.50 yen


 NOTE - Fuji Pharma.
*Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T